EASL Podcasts

Renal dysfunction is a significant concern for patients with liver cirrhosis, affecting nearly 50% of those hospitalised and leading to various complications that can reduce survival rates. Recently, the diagnostic criteria for acute kidney injury (AKI) and hepatorenal syndrome (HRS) have been updated to better capture the diversity and incidence of these conditions in cirrhotic patients.

This episode of EASL Studio:

• Explores the updated definitions and standardisation of AKI in the context of cirrhosis.
• Reviews recent clinical trials, including ATTIRE and CONFIRM, and their implications for patient care.
• Provides a critical analysis of current and emerging strategies for managing renal dysfunction in cirrhosis.

Faculty

• Debbie Shawcross (Moderator)
• Pere Gines (Faculty)
• Salvatore Piano (Faculty)
• Florence Wong (Faculty)

Related episodes

• EASL Studio from EASL Congress 2024: Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention
• EASL Studio S6E8: Is there a role for measuring blood ammonia in patients with cirrhosis?
• EASL Studio S6E5: JHEP Live: Should the compensated advanced chronic liver disease (cACLD) concept replace cirrhosis?
• EASL Studio S5E11: Statins in cirrhosis: The window hypothesis again, or just a closed window?
• EASL Studio from EASL Congress 2023: Liver cirrhosis in 2023: Unmet needs and how to address them
• EASL Studio S4E17: Albumin in Cirrhosis: For all, some, or none?

This episode is sponsored by Mallinckrodt Pharmaceuticals. Mallinckrodt Pharmaceuticals have had no input into the content of this EASL Studio episode.

All EASL Studio Podcasts are available on EASL Campus.

Arrivederci Milano, hallo Amsterdam!

Faculty

• Aleksander Krag (Moderator)
• Debbie Shawcross (Moderator)
• Cyrielle Caussy (Faculty)
• Ana Lleo (Faculty)
• Francesco Negro (Faculty)
• Vlad Ratziu (Faculty)
• Virginia Hernández-Gea (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

EASL Studio - Education at the heart of EASL’s mission

Faculty

• Sven Francque (Moderator)
• Krista Rombouts (Faculty)
• Rajeshwar Mookerjee (Faculty)
• Henning Grønbæk (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

EASL Studio - Landmark studies at the EASL Congress 2024

Faculty

• Thomas Berg (Moderator)
• Rajiv Jalan (Faculty)
• Verena Keitel (Faculty)
• Frank Tacke (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

EASL Studio - SLD nomenclature: Need for refinement?

Faculty

• Aleksander Krag (Moderator)
• Meena Bansal (Faculty)
• Sven Francque (Faculty)
• Alexandre Louvet (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

EASL Studio - Exploring new frontiers: The AI liver taskforce initiative

Faculty

• Eric Trépo (Moderator)
• Tom Lüdde (Faculty)
• Jakob Kather (Faculty)
• Raquel Pérez-López (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

EASL Studio - Advances in systemic treatments in liver cancer

Faculty

• Josep Llovet (Moderator)
• Massimo Iavarone (Faculty)
• Matthias Pinter (Faculty)
• Jessica Zucman-Rossi (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

EASL Studio - Buongiorno Milano: What not to miss during EASL Congress.

Faculty

• Aleksander Krag (Moderator)
• Debbie Shawcross (Faculty)
• Thomas Berg (Faculty)
• Ahmed Elsharkawy (Faculty)

All EASL Studio Podcasts are available on EASL Campus.

This session covers a wide range of topics relevant to the current landscape of viral hepatitis, including elimination efforts, resistance to direct-acting antivirals (DAAs), surveillance methods during and after therapy. This talk provides you with valuable insights through an up-to-date overview of the latest developments and challenges in the field.

Faculty

• Thomas Berg (Moderator)
• Jordan Feld (Faculty)
• Norah Terrault (Faculty)
• Heiner Wedemeyer (Faculty)

This episode is scheduled in honour of the United States’ Viral Hepatitis Awareness Month.

This EASL Studio is supported by GSK and Vir Biotechnology. EASL has received no input from GSK or Vir Biotechnology with regards to the content of this programme.

Related episodes

• Season 6, Episode 2: Why do we need HBV functional cure?
• Season 5, Episode 8: JHEP Live: Hepatitis Delta’s Latest Debate: Updates Straight from EASL’s Slate
• Season 5, Episode 3: Zoonotic Hepatitis E: What’s hot in 2023?
• EASL Studio at the EASL Congress 2023: The bumpy road of Hepatitis B drug development successes and challenges
• Season 4, Episode 19: HDV: The devil becomes treatable
• Season 4, Episode 1: Hepatitis B elimination: how far behind are we and what do we need to change to achieve it?

All EASL Studio Podcasts are available on EASL Campus.

This insightful discussion is centred on the burgeoning field of endohepatology, where advanced endoscopic techniques revolutionise hepatology practice. With this episode, explore the broad scope of endoscopic procedures (including EUS-guided liver biopsy, portal pressure measurement, and gastric varices embolisation) and their transformative impact on diagnostics and therapeutic interventions in liver disease.

To learn even more about endoscopic procedures in hepatology, take a look at this study by Wim Laleman et al., published in January 2024 in the Journal of Hepatology.

Faculty

• Wim Laleman (Moderator)
• Andres Cardenas (Faculty)
• Gavin Johnson (Faculty)
• Reem Sharaiha (Faculty)

Related episodes

• Season 6, Episode 11: Assessment of clinically significant portal hypertension in 2024 – Is it time to say goodbye to invasive measurements?
• Season 3, Episode 15: Chronic portal vein thrombosis: anticoagulation and interventional radiology for all patients?
• Season 2, Episode 14: Elastography – The new non-invasive gold standard in portal hypertension?

All EASL Studio Podcasts are available on EASL Campus.